Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

Seto Wai-Kay; Hui Aric Josun; Wong Vincent Wai-Sun; Wong Grace Lai-Hung; Liu Kevin Sze-Hang; Lai Ching-Lung; Yuen Man-Fung; Chan Henry Lik-Yuen

首页> 外文期刊>Gut: Journal of the British Society of Gastroenterology >Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

【24h】

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

机译：恩替卡韦在亚洲乙型肝炎e抗原阴性慢性乙型肝炎患者中的治疗终止：一项多中心前瞻性研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and objective The off-treatment durability of nucleos(t)ide analogue therapy in Asian hepatitis B e antigen (HBeAg) negative chronic hepatitis B (CHB) and the role of hepatitis B surface antigen (HBsAg) levels in predicting off-treatment durability has not been well investigated.

机译：背景与目的核苷酸类似物疗法在亚洲乙型肝炎e抗原（HBeAg）阴性慢性乙型肝炎（CHB）中的治疗后持久性以及乙肝表面抗原（HBsAg）水平在预测治疗后持久性中的作用尚未得到充分调查。

著录项

来源
《Gut: Journal of the British Society of Gastroenterology》 |2015年第4期|共6页
作者
Seto Wai-Kay; Hui Aric Josun; Wong Vincent Wai-Sun; Wong Grace Lai-Hung; Liu Kevin Sze-Hang; Lai Ching-Lung; Yuen Man-Fung; Chan Henry Lik-Yuen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study [J] . Seto Wai-Kay, Hui Aric Josun, Wong Vincent Wai-Sun, Gut: Journal of the British Society of Gastroenterology . 2015,第4期

机译：恩替卡韦在亚洲乙型肝炎e抗原阴性慢性乙型肝炎患者中的治疗终止：一项多中心前瞻性研究
2. A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir [J] . HaM., ZhangG., DiaoS., Archives of virology . 2012,第2期

机译：对阿德福韦有严格戒烟标准的乙肝e抗原阴性慢性乙肝患者的前瞻性临床研究
3. A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir [J] . Minghao Ha, Guotong Zhang, Shu Diao, Archives of Virology . 2012,第2期

机译：对阿德福韦有严格戒断标准的乙肝e抗原阴性慢性乙肝患者的前瞻性临床研究
4. Treatment of interferon non-responder patients with chronic hepatitis C in Asia [C] . M. NISHIOK Falk Symposium . 2007

机译：亚洲慢性丙型肝炎干扰素非响应者患者的治疗
5. Incidence, Durability, and Clinical Outcomes of Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B [D] . Yip, Cheuk Fung. 2019

机译：慢性乙型肝炎患者乙型肝炎表面抗原血管疮的发病率，耐久性和临床结果
6. Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B [O] . Kwan Sik Lee, Young-Oh Kweon, Soon-Ho Um, 2017

机译：恩替卡韦与拉米夫定治疗5年的疗效和安全性：韩国乙型肝炎e抗原阴性慢性乙型肝炎患者的随机对照试验
7. Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients [O] . Yuan-wang Qiu, Li-hua Huang, Wen-long Yang, 2016

机译：乙型肝炎e抗原血清学转换的乙型肝炎表面抗原定量预测乙型肝炎e抗原阳性患者停用恩替卡韦后病毒学复发

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study

摘要

著录项

相似文献

相关主题

期刊订阅